These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 28282812)

  • 1. The Identification of Alpha-Synuclein as the First Parkinson Disease Gene.
    Nussbaum RL
    J Parkinsons Dis; 2017; 7(s1):S43-S49. PubMed ID: 28282812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Synuclein 2.0 - Moving towards Cell Type Specific Pathophysiology.
    Thakur P; Chiu WH; Roeper J; Goldberg JA
    Neuroscience; 2019 Aug; 412():248-256. PubMed ID: 31202707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease.
    Langston JW; Sastry S; Chan P; Forno LS; Bolin LM; Di Monte DA
    Exp Neurol; 1998 Dec; 154(2):684-90. PubMed ID: 9878203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants and animal models in SNCA and Parkinson disease.
    Deng H; Yuan L
    Ageing Res Rev; 2014 May; 15():161-76. PubMed ID: 24768741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The G209A mutation in the alpha-synuclein gene in Brazilian families with Parkinson's disease.
    Teive HA; Raskin S; Iwamoto FM; Germiniani FM; Baran MH; Werneck LC; Allan N; Quagliato E; Leroy E; Ide SE; Polymeropoulos MH
    Arq Neuropsiquiatr; 2001 Sep; 59(3-B):722-4. PubMed ID: 11593272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autosomal dominant Parkinson's disease and alpha-synuclein.
    Polymeropoulos MH
    Ann Neurol; 1998 Sep; 44(3 Suppl 1):S63-4. PubMed ID: 9749575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal dominant Parkinson's disease and the route to new therapies.
    Morris HR
    Expert Rev Neurother; 2007 Jun; 7(6):649-56. PubMed ID: 17563248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease?
    Volpicelli-Daley LA; Kirik D; Stoyka LE; Standaert DG; Harms AS
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl 1):131-155. PubMed ID: 27018978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 200-year journey of Parkinson disease: Reflecting on the past and looking towards the future.
    Fahn S
    Parkinsonism Relat Disord; 2018 Jan; 46 Suppl 1():S1-S5. PubMed ID: 28784297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Birth of the Modern Era of Parkinson's Disease Genetics.
    Singleton AB; Hardy JA; Gasser T
    J Parkinsons Dis; 2017; 7(s1):S87-S93. PubMed ID: 28282818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Threonine 53 in alpha-synuclein is conserved in long-living non-primate animals.
    Larsen K; Hedegaard C; Bertelsen MF; Bendixen C
    Biochem Biophys Res Commun; 2009 Sep; 387(3):602-5. PubMed ID: 19619507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death.
    Jiang H; Wu YC; Nakamura M; Liang Y; Tanaka Y; Holmes S; Dawson VL; Dawson TM; Ross CA; Smith WW
    Neurobiol Aging; 2007 Nov; 28(11):1709-17. PubMed ID: 16978743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulation of α-synuclein in Parkinson's disease: Insight from epigenetic structure and transcriptional regulation of SNCA.
    Guhathakurta S; Bok E; Evangelista BA; Kim YS
    Prog Neurobiol; 2017 Jul; 154():21-36. PubMed ID: 28445713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson disease: α-synuclein mutational screening and new clinical insight into the p.E46K mutation.
    Pimentel MM; Rodrigues FC; Leite MA; Campos Júnior M; Rosso AL; Nicaretta DH; Pereira JS; Silva DJ; Della Coletta MV; Vasconcellos LF; Abreu GM; Dos Santos JM; Santos-Rebouças CB
    Parkinsonism Relat Disord; 2015 Jun; 21(6):586-9. PubMed ID: 25817515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of Gaucher Disease Mutations in Parkinson Disease.
    Vilageliu L; Grinberg D
    Curr Protein Pept Sci; 2017; 18(7):758-764. PubMed ID: 26965692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of alpha-synuclein gene multiplications in early-onset Parkinson's disease and dementia with Lewy bodies.
    Hofer A; Berg D; Asmus F; Niwar M; Ransmayr G; Riemenschneider M; Bonelli SB; Steffelbauer M; Ceballos-Baumann A; Haussermann P; Behnke S; Krüger R; Prestel J; Sharma M; Zimprich A; Riess O; Gasser T
    J Neural Transm (Vienna); 2005 Sep; 112(9):1249-54. PubMed ID: 15622440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rescue of alpha-synuclein cytotoxicity by insulin-like growth factors.
    Kao SY
    Biochem Biophys Res Commun; 2009 Jul; 385(3):434-8. PubMed ID: 19470380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-Synuclein gene duplications in sporadic Parkinson disease.
    Theuns J; Van Broeckhoven C
    Neurology; 2008 Jan; 70(1):7-9. PubMed ID: 18166703
    [No Abstract]   [Full Text] [Related]  

  • 20. The heterozygous A53T mutation in the alpha-synuclein gene in a Chinese Han patient with Parkinson disease: case report and literature review.
    Xiong WX; Sun YM; Guan RY; Luo SS; Chen C; An Y; Wang J; Wu JJ
    J Neurol; 2016 Oct; 263(10):1984-92. PubMed ID: 27393118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.